Here, we conducted the integrated immunogenomic analysis of clinical specimens from The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) datasets across various cancer types and 157 cancer patients who received PD-1 blockade with available transcriptomic data and treatment outcomes. This evidence concerns the gene PDCD1 and cancer.